Log in
Enquire now
‌

US Patent 8183238 Bicyclic and tricyclic compounds as KAT II inhibitors

Patent 8183238 was granted and assigned to Pfizer Limited on May, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Compounds of Formula X:

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8183238 Bicyclic and tricyclic compounds as KAT II inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.